SCHEMBL2118776

SCHEMBL2118776

CO[C@]1(n2ccc(N)nc2=O)C[C@H](O)[C@@H](CO)O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.46
PDE4D Q08499 1/20 0.46
SLC29A1 Q99808 1/20 0.46
LMNA P02545 4/20 0.46
THRB P10828 1/20 0.46
MTOR P42345 1/20 0.46
MDM2 Q00987 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
CACNA1F O60840 2/20 0.39
ALB P02768 2/20 0.39
MAPT P10636 2/20 0.39
CACNA1D Q01668 2/20 0.39
CACNA1S Q13698 2/20 0.39
CACNA1C Q13936 2/20 0.39
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ADRB1 P08588 1/20 0.34
DNMT1 P26358 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992472 0.85 PDE3A (0.46) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL3424602 0.83 PDE3A (0.47) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL28379714 0.83 PDE3A (0.47) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL1939478 0.83 PDE3A (0.47) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL1962181 0.83 PDE3A (0.45) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL51650 0.82 PDE3A (0.46) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL4971926 0.82 PDE3A (0.46) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL3038818 0.82 PDE3A (0.52) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL3449198 0.82 PDE3A (0.46) PDE3APDE4DSLC29A1LMNATHRB
SCHEMBL7794942 0.82 PDE3A (0.46) PDE3APDE4DSLC29A1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790374-B2 Process for sequence saturation mutagenesis (SeSaM) BASF AKTIENGESELLSCHAFT (DE) 2010-09-07 US claimed
EP-1670914-B1 A PROCESS FOR SEQUENCE SATURATION MUTAGENESIS (SESAM) BASF AG (DE) 2008-01-23 EP claimed
US-20060223148-A1 Process for sequence saturation mutagenesis (sesam) BASF AKTIENGESCHAFT (DE) 2006-10-05 US claimed
EP-1670914-A1 A PROCESS FOR SEQUENCE SATURATION MUTAGENESIS (SESAM) BASF AKTIENGESELLSCHAFT (DE) 2006-06-21 EP claimed
WO-2005035757-A1 A PROCESS FOR SEQUENCE SATURATION MUTAGENESIS (SESAM) BASF AKTIENGESELLSCHAFT (DE) 2005-04-21 WO claimed
WO-2014066084-A1 NUCLEIC ACID MODULATORS OF ALPHA2BETA1 NOVAMEDICA LIMITED LIABILITY COMPANY (RU) 2014-05-01 WO disclosed
WO-2014066142-A1 NUCLEIC ACID REGULATION OF GROWTH ARREST-SPECIFIC PROTEIN 6 (GAS6) NOVAMEDICA LIMITED LIABILITY COMPANY (RU) 2014-05-01 WO disclosed
EP-2627769-A2 NUCLEIC ACID MODULATORS OF CLEC-2 Regado Biosciences, Inc. (US) 2013-08-21 EP disclosed
US-20120095085-A1 NUCLEIC ACID MODULATORS OF CLEC-2 TOBIRA THERAPEUTICS, INC. 2012-04-19 US disclosed
WO-2012051571-A2 NUCLEIC ACID MODULATORS OF CLEC-2 REGADO BIOSCIENCES, INC. (US) 2012-04-19 WO disclosed
US-7790374-B2 Process for sequence saturation mutagenesis (SeSaM) BASF AKTIENGESELLSCHAFT (DE) 2010-09-07 US disclosed
EP-1670914-B1 A PROCESS FOR SEQUENCE SATURATION MUTAGENESIS (SESAM) BASF AG (DE) 2008-01-23 EP disclosed
US-20060223148-A1 Process for sequence saturation mutagenesis (sesam) BASF AKTIENGESCHAFT (DE) 2006-10-05 US disclosed
EP-0439550-A4 DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES 1991-09-25 EP disclosed
EP-0439550-A1 DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES DNAX RESEARCH INSTITUTE OF MOLECULAR AND CELLULAR BIOLOGY, INC. (US) 1991-08-07 EP disclosed
WO-1990004652-A1 DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES DNAX RESEARCH INSTITUTE OF MOLECULAR AND CELLULAR BIOLOGY, INC. (US) 1990-05-03 WO disclosed